No Data
Form 144 | Dyne Therapeutics(DYN.US) Insider Proposes to Sell 49.25 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Nov 14, $Dyne Therapeutics(DYN.US)$ Insider ForDyne B.V. intends to sell 1.5 million shares of its common stock on Nov 14, with a total market value of approximately $49.25
Dyne Therapeutics Reveals Q3 Results and Trial Updates
Dyne Therapeutics Is Maintained at Buy by Chardan Capital
Oppenheimer Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Maintains Target Price $55
Oppenheimer Sticks to Their Buy Rating for Dyne Therapeutics (DYN)
Express News | Dyne Therapeutics Inc : Raymond James Cuts Target Price to $49 From $56